21783418

Source:http://linkedlifedata.com/resource/pubmed/id/21783418

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0684249, umls-concept:C1122962, umls-concept:C1135135, umls-concept:C1414313
pubmed:issue	8
pubmed:dateCreated	2011-8-2
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21783418-21783417
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100957246
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Quinazolines, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/erlotinib
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1474-5488
pubmed:author	pubmed-author:MitsudomiTetsuyaT
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	710-1
pubmed:meshHeading	pubmed-meshheading:21783418-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21783418-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:21783418-Female, pubmed-meshheading:21783418-Humans, pubmed-meshheading:21783418-Lung Neoplasms, pubmed-meshheading:21783418-Male, pubmed-meshheading:21783418-Protein Kinase Inhibitors, pubmed-meshheading:21783418-Quinazolines, pubmed-meshheading:21783418-Receptor, Epidermal Growth Factor
pubmed:year	2011
pubmed:articleTitle	Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?
pubmed:affiliation	Aichi Cancer Center Hospital, Nagoya, Japan. mitsudom@aichi-cc.jp
pubmed:publicationType	Journal Article, Comment